NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/26/2021
Back to search
Official data from USPTO
HEMOKINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
10/26/2021
Trademark type
Word
Nice classes
5
Filing date
02/03/1997
Registration date
11/13/2001
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/26/2021
Last transaction
10/26/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/13/2001
First use in commerce
03/13/2001
Drawing code
1
Owner type
01
Owner location
Weston, MA
Examiner
CHICOSKI, JENNIFER D
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Perrine, Susan P.
Representatives
Perrine, Susan P.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical compositions containing chemical or biological agents that stimulate the proliferation of mammalian cells and regulate the expression of eukaryotic genes for use as pharmaceutical supplements and in the treatment of neoplasticfamilial and infections diseasesassociated disorderscancermetastatic diseasesinflammatory disorderschronic diseasesanemias and other blood cell deficiencieshemoglobinopathiesorgan failure and viral infection
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/26/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/26/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/26/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
06/14/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/06/2011
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/06/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/06/2011
E89R
TEAS SECTION 8 & 9 RECEIVED
11/02/2011
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/04/2009
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
09/13/2008
PLGL
ASSIGNED TO PARALEGAL
08/18/2008
E15R
TEAS SECTION 15 RECEIVED
08/08/2008
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/04/2008
PLGL
ASSIGNED TO PARALEGAL
05/20/2008
ES8R
TEAS SECTION 8 RECEIVED
05/05/2008
CFIT
CASE FILE IN TICRS
01/16/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/20/2003
R.PR
REGISTERED-PRINCIPAL REGISTER
11/13/2001
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/09/2001
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/29/2001
IUAF
USE AMENDMENT FILED
03/28/2001
EX2G
SOU EXTENSION 2 GRANTED
12/18/2000
EXT2
SOU EXTENSION 2 FILED
09/28/2000
EX1G
SOU EXTENSION 1 GRANTED
05/18/2000
EXT1
SOU EXTENSION 1 FILED
03/28/2000
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/28/1999
PUBO
PUBLISHED FOR OPPOSITION
07/06/1999
NPUB
NOTICE OF PUBLICATION
06/04/1999
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/28/1999
DOCK
ASSIGNED TO EXAMINER
09/03/1998
CNSL
LETTER OF SUSPENSION MAILED
09/03/1997
CNEA
EXAMINER'S AMENDMENT MAILED
08/22/1997
CNRT
NON-FINAL ACTION MAILED
08/18/1997
DOCK
ASSIGNED TO EXAMINER
08/18/1997
Continuous trademark protection
Get notified about every new filing that threatens HEMOKINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.